Bill Maughan
Stock Analyst at Clear Street
(0.61)
# 4,092
Out of 5,090 analysts
18
Total ratings
36.36%
Success rate
-23.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANNX Annexon | Initiates: Buy | $17 | $4.61 | +268.76% | 1 | Dec 2, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $93 | $7.02 | +1,224.79% | 1 | Oct 31, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $22 | $7.49 | +193.72% | 1 | Oct 15, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $44.26 | +125.94% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $234.13 | -18.85% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $56.88 | -20.89% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $1.80 | +733.33% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.08 | +733.33% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $38.78 | +72.77% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $27.70 | +282.67% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $0.53 | +4,452.35% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.07 | +748.66% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $96.14 | -53.19% | 1 | Nov 2, 2023 |
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $4.61
Upside: +268.76%
Korro Bio
Oct 31, 2025
Initiates: Buy
Price Target: $93
Current: $7.02
Upside: +1,224.79%
Wave Life Sciences
Oct 15, 2025
Initiates: Buy
Price Target: $22
Current: $7.49
Upside: +193.72%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $44.26
Upside: +125.94%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $234.13
Upside: -18.85%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $56.88
Upside: -20.89%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.80
Upside: +733.33%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.08
Upside: +733.33%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $38.78
Upside: +72.77%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $27.70
Upside: +282.67%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.53
Upside: +4,452.35%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $7.07
Upside: +748.66%
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $96.14
Upside: -53.19%